Elms Steve (CIK 0001250195)

Latest company ownership

Shares held
10,100,000
Last filed at
Jul 15, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
2,830,992
Last filed at
Dec 9, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q3 2025Q4
Shares held
1,837,125
Last filed at
Apr 27, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4
Shares held
137,330
Last filed at
Nov 19, 2025
Confidence Score
50.1
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
37,541
Last filed at
Jun 16, 2025
Confidence Score
48.4
2025Q4
Confidence Score History
2013Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 12, 2025 Jun 16, 2025 ADMA BIOLOGICS, INC. Director Sell 16.3 -425,621 -16.73% ✗ $8.8M
Dec 23, 2024 Dec 26, 2024 Marker Therapeutics, Inc. Director Buy 83.8 +11,085 3.49% ✗ $35.5K
Mar 18, 2024 Mar 19, 2024 ADMA BIOLOGICS, INC. Director Sell 17.5 -461,716 -17.40% ✗ $2.8M
Mar 13, 2024 Mar 15, 2024 ADMA BIOLOGICS, INC. Director Sell 16.3 -1,038,284 -28.12% ✗ $6.3M
Mar 16, 2021 Mar 18, 2021 Marker Therapeutics, Inc. Director Buy 100.0 +1,142,857 56.66% ✗ $2M
Jul 15, 2019 Jul 15, 2019 Viracta Therapeutics, Inc. 10% Owner Buy 100.0 +2,500,000 32.89% ✗ $1.5M
Dec 9, 2015 Dec 9, 2015 T2 Biosystems, Inc. Director Buy 100.0 +307,692 12.19% ✗ $3M
Apr 23, 2015 Apr 27, 2015 Esperion Therapeutics, Inc. 10% Owner Sell 15.0 -217,469 -5.49% ✗ $23.5M
Aug 12, 2014 Aug 14, 2014 T2 Biosystems, Inc. 10% Owner Buy 100.0 +454,545 21.97% ✗ $5M
Oct 22, 2013 Oct 23, 2013 ADMA BIOLOGICS, INC. 10% Owner Buy 100.0 +411,765 12.83% ✗ $3.5M
Jul 1, 2013 Jul 1, 2013 Esperion Therapeutics, Inc. 10% Owner Buy 100.0 +238,119 13.11% ✗ $3.3M